Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized heparin versus placebo in mechanically ventilated adult burn patients with inhalation trauma
NL-OMON39556Phase 3Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in Inhalation injury and acute lung injury (ALI) comparing Nebulized heparin with Placebo (2 arms). Primary endpoint: Ventilator-free days through day 28. Started Jan 2014; status: active, not recruiting.
02
Drugs
heparin
03
Conditions
Inhalation injuryacute lung injury (ALI)
Beyond the preview
Go deeper on NL-OMON39556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39556.